Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 174,579 | 90,788 | 65,218 | 69,268 | 81,834 |
| Marketable Securities | 213,675 | 335,204 | 248,000 | 306,350 | 273,317 |
| Receivables | 6,655 | 6,950 | 31,300 | 36,078 | 16,627 |
| TOTAL | $405,779 | $443,475 | $354,582 | $421,542 | $381,254 |
| Non-Current Assets | |||||
| PPE Net | 18,997 | 19,414 | 20,630 | 21,940 | 22,344 |
| Other Non-Current Assets | 27,056 | 26,154 | 28,190 | 27,254 | 28,136 |
| TOTAL | $46,053 | $45,568 | $48,820 | $49,194 | $50,480 |
| Total Assets | $451,832 | $489,043 | $403,402 | $470,736 | $431,734 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 4,061 | 7,137 |
| Accounts payable and accrued liabilities | 6,216 | 6,086 | 7,511 | 9,440 | 5,525 |
| Accrued Expenses | 45,312 | 43,002 | 44,823 | 53,159 | 30,787 |
| TOTAL | $131,291 | $129,985 | $79,509 | $93,746 | $73,606 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 72,560 | 73,964 | 20,502 | 20,666 | 23,983 |
| aiOther Non-Current Liabilities | 191,322 | 185,192 | 179,556 | 173,962 | 167,627 |
| TOTAL | $209,321 | $206,882 | $225,869 | $227,341 | $245,781 |
| Total Liabilities | $340,612 | $336,867 | $305,378 | $321,087 | $319,387 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,459 | 81,964 | 81,794 | 62,442 | 60,953 |
| Common Shares | 82 | 82 | 62 | 61 | 61 |
| Retained earnings | -714,426 | -665,639 | -617,621 | -559,408 | -590,473 |
| Other shareholders' equity | 106 | -163 | -113 | 21 | 7 |
| TOTAL | $111,220 | $152,176 | $98,024 | $149,649 | $112,347 |
| Total Liabilities And Equity | $451,832 | $489,043 | $403,402 | $470,736 | $431,734 |